US CMS (Centers for Medicare & Medicaid Services) to explain extra data rules for new coverage-with-evidence product reimbursement
This article was originally published in Clinica
Executive Summary
The US Centers for Medicare & Medicaid Services (CMS) will issue a second draft guidance in the next few months fleshing out its evolving policy of requiring additional data collection as a condition of coverage for certain new products or services, the agency has disclosed in a fact sheet.